Database : MEDLINE Search on : leucomycins [Words] References found : 1699 [refine] Displaying: 1 .. 10   in format [Detailed]

page 1 of 170

go to page

1 / 1699

MEDLINE

select to print Photocopy Full text

[PMID]: 20688466 [Au] Autor: Burnell KJ; Boyce N; Hunt N [Ad] Address: Department of Mental Health Sciences, University College London, 1st Floor Charles Bell House, 67-73 Riding House Street, London W1W 7EJ, UK. k.burnell@ucl.ac.uk [Ti] Title: A Good War? Exploring British veterans' moral evaluation of deployment. [So] Source: J Anxiety Disord;25(1):36-42, 2011 Jan. [Is] ISSN: 1873-7897 [Cp] Country of publication: Netherlands [La] Language: eng [Ab] Abstract: Historically, war trauma research has concentrated on the relationship between level of exposure and development of post-traumatic symptoms. More recently, it has been recognized that intra- and interpersonal differences can mediate how service personnel are affected by their experiences. This paper is a qualitative study exploring moral evaluations of 30 British male veterans towards their deployment in conflicts from WWII to the most recent Iraq War (2003-2009). Retrospective thematic analysis is used to explore moral evaluation and societal support. Four categories emerged based on veterans' moral evaluation of deployment: justifiable, implicitly justifiable, unclear, and unjustifiable. Analysis revealed broad differences between these groups. Veterans able to justify their experiences reported more positive aspects of both deployment and societal support than those unable to justify their deployment. These findings make clear the importance of future research exploring the interactions between civilians and service personnel, and the impact this has on mental health. [Mh] MeSH terms primary: Iraq War, 2003 - 2011 Morals Veterans/psychology [Mh] MeSH terms secundary: Adult Aged Humans Interviews as Topic Leucomycins Male Mental Health Social Perception [Pt] Publication type: JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T [Nm] Name of substance: 0 (Leucomycins); 35457-80-8 (midecamycin) [Em] Entry month: 1104 [Cu] Class update date: 121115 [Lr] Last revision date: 121115 [Js] Journal subset: IM [Da] Date of entry for processing: 101221 [St] Status: MEDLINE [do] DOI: 10.1016/j.janxdis.2010.07.003

2 / 1699

MEDLINE

select to print Photocopy Full text

[PMID]: 20414322 [Au] Autor: Anzai Y; Sakai A; Li W; Iizaka Y; Koike K; Kinoshita K; Kato F [Ad] Address: Department of Microbiology, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Chiba, Japan. yanzai@phar.toho-u.ac.jp [Ti] Title: Isolation and characterization of 23-O-mycinosyl-20-dihydro-rosamicin: a new rosamicin analogue derived from engineered Micromonospora rosaria. [So] Source: J Antibiot (Tokyo);63(6):325-8, 2010 Jun. [Is] ISSN: 0021-8820 [Cp] Country of publication: Japan [La] Language: eng [Mh] MeSH terms primary: Anti-Bacterial Agents/isolation & purification Kitasamycin/analogs & derivatives Leucomycins/isolation & purification Micromonospora/metabolism [Mh] MeSH terms secundary: Anti-Bacterial Agents/pharmacology Bacteria/drug effects Chromatography, High Pressure Liquid Genetic Engineering Leucomycins/pharmacology Microbial Sensitivity Tests Micromonospora/genetics Nuclear Magnetic Resonance, Biomolecular [Pt] Publication type: JOURNAL ARTICLE [Nm] Name of substance: 0 (23-O-mycinosyl-20-dihydro-rosamicin); 0 (Anti-Bacterial Agents); 0 (Leucomycins); 1392-21-8 (Kitasamycin); 35834-26-5 (rosaramicin) [Em] Entry month: 1007 [Js] Journal subset: IM [Da] Date of entry for processing: 100628 [St] Status: MEDLINE [do] DOI: 10.1038/ja.2010.38

3 / 1699

MEDLINE

select to print Photocopy Full text

[PMID]: 19408026 [Au] Autor: Anzai Y; Iizaka Y; Li W; Idemoto N; Tsukada S; Koike K; Kinoshita K; Kato F [Ad] Address: Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Chiba 274-8510, Japan. yanzai@phar.toho-u.ac.jp [Ti] Title: Production of rosamicin derivatives in Micromonospora rosaria by introduction of D-mycinose biosynthetic gene with PhiC31-derived integration vector pSET152. [So] Source: J Ind Microbiol Biotechnol;36(8):1013-21, 2009 Aug. [Is] ISSN: 1476-5535 [Cp] Country of publication: England [La] Language: eng [Ab] Abstract: Some of the polyketide-derived bioactive compounds contain sugars attached to the aglycone core, and these sugars often impart specific biological activity to the molecule or enhance this activity. Mycinamicin II, a 16-member macrolide antibiotic produced by Micromonospora griseorubida A11725, contains a branched lactone and two different deoxyhexose sugars, D-desosamine and D-mycinose, at the C-5 and C-21 positions, respectively. The D-mycinose biosynthesis genes, mycCI, mycCII, mycD, mycE, mycF, mydH, and mydI, present in the M. griseorubida A11725 chromosome were introduced into pSET152 under the regulation of the promoter of the apramycin-resistance gene aac(3)IV. The resulting plasmid pSETmycinose was introduced into Micromonospora rosaria IFO13697 cells, which produce the 16-membered macrolide antibiotic rosamicin containing a branched lactone and D-desosamine at the C-5 position. Although the M. rosaria TPMA0001 transconjugant exhibited low rosamicin productivity, two new compounds, IZI and IZII, were detected in the ethylacetate extract from the culture broth. IZI was identified as a mycinosyl rosamicin derivative, 23-O-mycinosyl-20-deoxo-20-dihydro-12,13-deepoxyrosamicin (MW 741), which has previously been synthesized by a bioconversion technique. This is the first report on production of mycinosyl rosamicin-derivatives by a engineered biosynthesis approach. The integration site PhiC31attB was identified on M. rosaria IFO13697 chromosome, and the site lay within an ORF coding a pirin homolog protein. The pSETmycinose could be useful for stimulating the production of "unnatural" natural mycinosyl compounds by various actinomycete strains using the bacteriophage PhiC31 att/int system. [Mh] MeSH terms primary: Anti-Bacterial Agents/metabolism Genetic Engineering/methods Leucomycins/metabolism Macrolides/metabolism Micromonospora/genetics Micromonospora/metabolism [Mh] MeSH terms secundary: Bacteriophages/genetics DNA, Bacterial/chemistry DNA, Bacterial/genetics Genes, Bacterial Genetic Vectors Molecular Sequence Data Plasmids Sequence Analysis, DNA [Pt] Publication type: JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T [Nm] Name of substance: 0 (Anti-Bacterial Agents); 0 (DNA, Bacterial); 0 (Leucomycins); 0 (Macrolides); 35834-26-5 (rosaramicin) [Em] Entry month: 0909 [Js] Journal subset: IM [Da] Date of entry for processing: 090723 [St] Status: MEDLINE [do] DOI: 10.1007/s10295-009-0579-y

4 / 1699

MEDLINE

select to print Photocopy

[PMID]: 19441724 [Au] Autor: Chernomortseva ES; Pokrovskii MV; Pokrovskaia TG; Artiushkova EB; Gureev VV [Ti] Title: [Experimental study of cardioprotective and endothelioprotective action of macrolides and azalides]. [So] Source: Eksp Klin Farmakol;72(2):29-31, 2009 Mar-Apr. [Is] ISSN: 0869-2092 [Cp] Country of publication: Russia (Federation) [La] Language: rus [Ab] Abstract: The cardioprotective and endothelioprotective effects of the macrolide antibiotics roxithromycin, azythromycin, and midecamycin have been studied on laboratory animals with models of the coronaro-occlusional myocardial infarction and endothelial dysfunction. The drugs led to a dose-dependent decrease in lethality, reduced the zone of necrosis of the left ventricle after coronary occlusion, and produced a positive effect on the functioning of endothelium. [Mh] MeSH terms primary: Anti-Bacterial Agents/therapeutic use Azithromycin/therapeutic use Cardiotonic Agents/therapeutic use Endothelium, Vascular/drug effects Leucomycins/therapeutic use Myocardial Infarction/drug therapy Roxithromycin/therapeutic use [Mh] MeSH terms secundary: Animals Coronary Occlusion/complications Endothelium, Vascular/physiopathology Male Myocardial Infarction/etiology Myocardial Infarction/physiopathology Rats Rats, Wistar Ventricular Function, Left/drug effects [Pt] Publication type: ENGLISH ABSTRACT; JOURNAL ARTICLE [Nm] Name of substance: 0 (Anti-Bacterial Agents); 0 (Cardiotonic Agents); 0 (Leucomycins); 35457-80-8 (midecamycin); 80214-83-1 (Roxithromycin); 83905-01-5 (Azithromycin) [Em] Entry month: 0906 [Js] Journal subset: IM [Da] Date of entry for processing: 090515 [St] Status: MEDLINE

5 / 1699

MEDLINE

select to print Photocopy

[PMID]: 19306580 [Au] Autor: Ma C; Wu L; Dai J; Zhou H; Li J; Sun X; Zhang K; Xia H; Wang Y [Ad] Address: Key Laboratory of Biotechnology of Antibiotics, Ministry of Health, Institute of Medicinal Biotechnolgy, CAMS & PUMC, Beijing 100050, China. [Ti] Title: [Acylation specificity of midecamycin 3-O-acyltransferase within Streptomyces spiramyceticus F21]. [So] Source: Sheng Wu Gong Cheng Xue Bao;24(12):2086-92, 2008 Dec. [Is] ISSN: 1000-3061 [Cp] Country of publication: China [La] Language: chi [Ab] Abstract: Spiramycin and midecamycin are 16-membered macrolide antibiotics with very similar chemical structures. Spiramycin has three components, namely spiramycin I, II and III. Spiramycin II and III are, respectively, the O-acetyl and propionyl derivatives at C3-hydroxyl group of spiramycin I. Midecamycin has four components, and the C3-hydroxyl group of midecamycin is all O-propionylated. The enzyme adding acyl group(s) at the C3-hydroxyl group during the biosynthesis of spiramycin and midecamycin is 3-O-acyltransferase. The 3-O-acyltransferases for spiramycin and midecamycin are also very similar, and presume to function when exchanged. To explore whether the 3-O-acyltransferase for midecamycin biosynthesis hold still the character of selective and efficient propionylation for spiramycin I at its C3-hydroxyl group, we inserted mdmB, the 3-O-acyltransferase gene from Streptomyces mycarofaciens ATCC 21454 for midecamycin biosynthesis, into a mutant strain of S. spiramyceticus F21, in which the 3-O-acyltransferase gene for spiramycin biosynthesis, sspA, was deleted; and the mdmB was integrated exactly into the chromosomal site where the sspA was deleted. We name this "hybrid" strain as SP-mdmB. HPLC analysis of the spiramycin produced by SP-mdmB showed that spiramycin I was still the major component, although the relative proportions of both spiramycin II and III increased significantly. We thus conclude that MdmB from Streptomyces mycarofaciens ATCC 21454 for midecamyicn biosynthesis do not hold the character of selective and efficient propionylation for spiramycin I within S. spiramyceticus F21, and this character is possibly limited in Streptomyces mycarofaciens ATCC 21454 for midecamycin biosynthesis. [Mh] MeSH terms primary: Acyltransferases/metabolism Leucomycins/biosynthesis Spiramycin/biosynthesis Streptomyces/enzymology [Mh] MeSH terms secundary: Acylation Acyltransferases/genetics Culture Media Genes, Bacterial Genetic Engineering/methods Streptomyces/genetics Substrate Specificity [Pt] Publication type: ENGLISH ABSTRACT; JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T [Nm] Name of substance: 0 (Culture Media); 0 (Leucomycins); 35457-80-8 (midecamycin); 8025-81-8 (Spiramycin); EC 2.3.- (Acyltransferases) [Em] Entry month: 1001 [Js] Journal subset: IM [Da] Date of entry for processing: 090324 [St] Status: MEDLINE

6 / 1699

MEDLINE

select to print Photocopy Full text

[PMID]: 18258437 [Au] Autor: Miura T; Kurihara K; Furuuchi T; Yoshida T; Ajito K [Ad] Address: Pharmaceutical Research Center, Meiji Seika Kaisha Ltd, 760 Morooka-cho, Kohoku-ku, Yokohama 222-8567, Japan. tomoaki_miura@meiji.co.jp [Ti] Title: Novel 16-membered macrolides modified at C-12 and C-13 positions of midecamycin A1 and miokamycin. Part 1: Synthesis and evaluation of 12,13-carbamate and 12-arylalkylamino-13-hydroxy analogues. [So] Source: Bioorg Med Chem;16(7):3985-4002, 2008 Apr 1. [Is] ISSN: 1464-3391 [Cp] Country of publication: England [La] Language: eng [Ab] Abstract: Design and synthesis of 16-membered macrolides modified at the C-12 and 13 positions are described. The compounds we report here have an arylalkylamino group attached to the C-12 position of the macrolactone. Both types of derivatives, 12,13-cyclic carbamates and non-carbamate analogues, were synthesized via 12-amino-13-hydroxy intermediates derived from 12,13-epoxide that was prepared by selective epoxidation at the C-12 and C-13 positions. 4'-Hydroxyl analogues were also prepared by acidic hydrolysis of a neutral sugar. These compounds were evaluated for in vitro antibacterial activity against respiratory tract pathogens. Some of these analogues exhibited an improved activity compared with the corresponding parent compound. [Mh] MeSH terms primary: Anti-Bacterial Agents/pharmacology Carbamates/chemical synthesis Carbamates/pharmacology Leucomycins/chemical synthesis Leucomycins/pharmacology Miocamycin/chemical synthesis Miocamycin/pharmacology [Mh] MeSH terms secundary: Alkylation Amination Anti-Bacterial Agents/chemical synthesis Anti-Bacterial Agents/chemistry Carbamates/chemistry Hydroxylation Ketolides/chemistry Leucomycins/chemistry Microbial Viability/drug effects Miocamycin/chemistry Molecular Structure [Pt] Publication type: JOURNAL ARTICLE [Nm] Name of substance: 0 (Anti-Bacterial Agents); 0 (Carbamates); 0 (Ketolides); 0 (Leucomycins); 35457-80-8 (midecamycin); 55881-07-7 (Miocamycin) [Em] Entry month: 0805 [Js] Journal subset: IM [Da] Date of entry for processing: 080414 [St] Status: MEDLINE [do] DOI: 10.1016/j.bmc.2008.01.027

7 / 1699

MEDLINE

select to print Photocopy

[PMID]: 17724653 [Au] Autor: Kotev MI; Ivanov PM [Ad] Address: Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. [Ti] Title: Molecular mechanics (MM3(pi)) conformational analysis of molecules containing conjugated pi-electron fragments: Leucomycin-V. [So] Source: Chirality;20(3-4):400-10, 2008 Mar. [Is] ISSN: 0899-0042 [Cp] Country of publication: United States [La] Language: eng [Ab] Abstract: The conformations of the 16-membered macrolide antibiotic leucomycin-V (1) were studied with molecular mechanics. Leucomycin-V contains a conjugated pi-electron fragment and necessitates special treatment with the MM3(pi) modeling protocol. Comparison was made with results from the standard MM3 scheme. The CONFLEX conformational search procedure was used for finding low-energy conformations. The computed data are indicative for the existence of mainly one conformation of the macro-ring of 1 and minor participation of several others. Intramolecular hydrogen bonds play important roles for the preferred geometry of the macro-ring and the conformations of the side chains. The most probable macro-ring conformation of 1 is very similar to the preferred conformation of another 16-ring macrolide antibiotic, tylosin. The same order of conformational preference for 1 was estimated with the MM3 and the MM3(pi) methods. Surprisingly, when changing the chirality of the C(9) macro-ring atom of 1, the two methods produced different order of conformational preferences for the 9-epi form (2), as well as enhanced population of several clusters of conformations. [Mh] MeSH terms primary: Leucomycins/chemistry [Mh] MeSH terms secundary: Anti-Bacterial Agents/chemistry Computer Simulation Electrons Hydrogen Bonding Models, Molecular Molecular Conformation Stereoisomerism Thermodynamics [Pt] Publication type: JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T [Nm] Name of substance: 0 (Anti-Bacterial Agents); 0 (Leucomycins) [Em] Entry month: 0805 [Js] Journal subset: IM [Da] Date of entry for processing: 080130 [St] Status: MEDLINE

8 / 1699

MEDLINE

select to print Photocopy

[PMID]: 17523431 [Au] Autor: Chervinets VM; Bondarenko VM; Samoukina AM; Chervinets IuV [Ti] Title: [Screening of nonpathogenic strains of Enterococcus faecium with antagonistic activity]. [So] Source: Zh Mikrobiol Epidemiol Immunobiol;(1):57-61, 2007 Jan-Feb. [Is] ISSN: 0372-9311 [Cp] Country of publication: Russia (Federation) [La] Language: rus [Ab] Abstract: Forty two strains of enterococci were isolated from feces of healthy adolescents. Strains were selected according to their antagonistic effects associated with bacteriocinogenic and microcinogenic activity. Resistance of enterococci to antibiotics, various concentrations of hydrochloric acid and bile, their level of production of organic acids and adhesiveness were determined. Characteristics related to pathogenicity were investigared in 5 microcinogenic strains of E. faecium with broad spectrum of antagonistic activity. Non-pathogenic microcin-producing strains of E. faecium resistant to physiological concentrations of hydrochloric acid and bile with broad spectrum of antagonistic activity against obligatory pathogenic and opportunistic microorganisms can be considered as possessing probiotic activity. [Mh] MeSH terms primary: Enterococcus faecium/physiology [Mh] MeSH terms secundary: Adolescent Anti-Bacterial Agents/pharmacology Antibiosis Bacterial Adhesion Bacteriocins/biosynthesis Bile Child Drug Resistance, Multiple, Bacterial Enterococcus faecium/drug effects Enterococcus faecium/isolation & purification Feces/microbiology Female Humans Hydrochloric Acid/pharmacology Leucomycins/biosynthesis Male Probiotics/isolation & purification Probiotics/pharmacology [Pt] Publication type: ENGLISH ABSTRACT; JOURNAL ARTICLE [Nm] Name of substance: 0 (Anti-Bacterial Agents); 0 (Bacteriocins); 0 (Leucomycins); 11049-15-3 (macrocin); 7647-01-0 (Hydrochloric Acid) [Em] Entry month: 0706 [Js] Journal subset: IM [Da] Date of entry for processing: 070525 [St] Status: MEDLINE

9 / 1699

MEDLINE

select to print Photocopy

[PMID]: 17476984 [Au] Autor: Korshunova GA; Sumbatian NV; Fedorova NV; Kuznetsova IV; Shishkina AV; Bogdanov AA [Ti] Title: [Peptide derivatives of tylosin-related macrolides]. [So] Source: Bioorg Khim;33(2):235-44, 2007 Mar-Apr. [Is] ISSN: 0132-3423 [Cp] Country of publication: Russia (Federation) [La] Language: rus [Ab] Abstract: Approaches to the synthesis of model compounds based on the tylosin-related macrolides desmycosin and O-mycaminosyltylonolide were developed using specially designed peptide derivatives of macrolide antibiotics to study the conformation and topography of the nascent peptide chain in the ribosome tunnel. A method for selective bromoacetylation of desmycosin at the hydroxyl group of mycinose was developed, which involves preliminary acetylation of mycaminose. The reaction of the 4"-bromoacetyl derivative of the antibiotic with cesium salts of the dipeptide Boc-Ala-Ala-OH and the hexapeptide MeOTr-Gly-Pro-Gly-Pro-Gly-Pro-OH led to the corresponding peptide derivatives of desmycosin. The protected peptides Boc-Ala-Ala-OH, Boc-Ala-Ala-Phe-OH, and Boc-Gly-Pro-Gly-Pro-Gly-Pro-OH were condensed with the C23-hydroxyl group of O-mycaminosyltylonolide. [Mh] MeSH terms primary: Anti-Bacterial Agents/chemical synthesis Leucomycins/chemistry Macrolides/chemical synthesis Oligopeptides/chemical synthesis Tylosin/analogs & derivatives [Mh] MeSH terms secundary: Acetylation Amino Acid Sequence Anti-Bacterial Agents/chemistry Bromine/chemistry Macrolides/chemistry Molecular Sequence Data Oligopeptides/chemistry Tylosin/chemistry [Pt] Publication type: ENGLISH ABSTRACT; JOURNAL ARTICLE [Nm] Name of substance: 0 (Anti-Bacterial Agents); 0 (Leucomycins); 0 (Macrolides); 0 (Oligopeptides); 11032-98-7 (tylosin B); 1401-69-0 (Tylosin); 61257-02-1 (mycaminosyltylonolide); 7726-95-6 (Bromine) [Em] Entry month: 0706 [Js] Journal subset: IM [Da] Date of entry for processing: 070504 [St] Status: MEDLINE

10 / 1699

MEDLINE

select to print Photocopy

[PMID]: 17257795 [Au] Autor: González de la Huebra MJ; Vincent U; von Holst C [Ad] Address: European Commission, Directorate General Joint Research Centre, Institute for Reference Materials and Measurements, Retieseweg 111, B-2440 Geel, Belgium. maria-jose.gonzalez-de-la-huebra@ec.europa.eu [Ti] Title: Sample preparation strategy for the simultaneous determination of macrolide antibiotics in animal feedingstuffs by liquid chromatography with electrochemical detection (HPLC-ECD). [So] Source: J Pharm Biomed Anal;43(5):1628-37, 2007 Apr 11. [Is] ISSN: 0731-7085 [Cp] Country of publication: England [La] Language: eng [Ab] Abstract: A novel and suitable clean-up method that allows, for the first time, the simultaneous determination of a rather large number of macrolide antibiotics (erythromycin, rosamicin, spiramycin, tylosin, kitasamycin and josamycin in feedingstuffs by high performance liquid chromatography with electrochemical detection (HPLC-ECD) is presented in this work. The effectiveness of the developed clean-up method allows the quantification of the target macrolides in poultry feed using standard calibration curves instead of matrix matched standards, which overcomes the general problem of finding representative blanks. Furthermore an additional back extraction included in the sample preparation procedure allows the determination of an additional macrolide (oleandomycin) with detection limits, expressed as apparent concentration in poultry feed, ranging from 0.04 to 0.22 mg kg(-1) and relative standard deviation values ranging from 3.6 to 10.1% depending on the target analyte. Moreover, this additional step has been proven to enlarge the scope of the method by the extension of its applicability, at the target level of concentration, to other animal feedingstuffs such as pig and cattle. The analysis of real feedingstuffs containing macrolides demonstrated the fitness for purpose of the whole analytical procedure as well as a good fitting between real and spiked samples. The proposed methods appeared therefore as a sound alternative in the frame of control (e.g. for post-screening purposes) and/or monitoring surveillance programmes at the target level of 1.0 mg kg(-1) established according to the reported lowest dosage of additive needed to lead a growth promoting effect. [Mh] MeSH terms primary: Animal Feed/analysis Anti-Bacterial Agents/analysis Chromatography, High Pressure Liquid/methods Chromatography, Liquid/methods Electrochemistry/methods Macrolides/analysis [Mh] MeSH terms secundary: Animals Anti-Bacterial Agents/isolation & purification Cattle Erythromycin/analysis Erythromycin/isolation & purification Josamycin/analysis Josamycin/isolation & purification Kitasamycin/analysis Kitasamycin/isolation & purification Leucomycins/analysis Leucomycins/isolation & purification Macrolides/isolation & purification Oleandomycin/analysis Oleandomycin/isolation & purification Poultry Spiramycin/analysis Spiramycin/isolation & purification Swine Time Factors Tylosin/analysis Tylosin/isolation & purification [Pt] Publication type: JOURNAL ARTICLE [Nm] Name of substance: 0 (Anti-Bacterial Agents); 0 (Leucomycins); 0 (Macrolides); 114-07-8 (Erythromycin); 1392-21-8 (Kitasamycin); 1401-69-0 (Tylosin); 16846-24-5 (Josamycin); 35834-26-5 (rosaramicin); 3922-90-5 (Oleandomycin); 8025-81-8 (Spiramycin) [Em] Entry month: 0706 [Js] Journal subset: IM [Da] Date of entry for processing: 070327 [St] Status: MEDLINE

---

page 1 of 170

go to page

Refine the search

Database : MEDLINE

Advanced form

		Search	in field
1			WordsSubject descriptorMajor Subject descriptorLimitsAuthorTitle wordsAbstract wordsLanguageCountry of publicationName of substancePersonal name as subjectJournalJournal DescriptorISSNPublication typeUnique identifierEntry monthYear of PublicationFulltextClass update dateDeCS CategoryDeCS Category explodedICD-10 CategorySubSetsAffiliation CountryAffiliation
2	and or and not		WordsSubject descriptorMajor Subject descriptorLimitsAuthorTitle wordsAbstract wordsLanguageCountry of publicationName of substancePersonal name as subjectJournalJournal DescriptorISSNPublication typeUnique identifierEntry monthYear of PublicationFulltextClass update dateDeCS CategoryDeCS Category explodedICD-10 CategorySubSetsAffiliation CountryAffiliation
3	and or and not		WordsSubject descriptorMajor Subject descriptorLimitsAuthorTitle wordsAbstract wordsLanguageCountry of publicationName of substancePersonal name as subjectJournalJournal DescriptorISSNPublication typeUnique identifierEntry monthYear of PublicationFulltextClass update dateDeCS CategoryDeCS Category explodedICD-10 CategorySubSetsAffiliation CountryAffiliation

Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information